United States — Food and Drug Administration & Bronstein, Gewirtz & Grossman, LLC

United States — Food and Drug Administration: The United States — Food and Drug Administration issued a Complete Response Letter to Aldeyra Therapeutics, citing a lack of substantial evidence for the efficacy of reproxalap, which triggered the stock price drop and subsequent lawsuits.

Bronstein, Gewirtz & Grossman, LLC: Bronstein, Gewirtz & Grossman, LLC is an investor-rights law firm that has filed a class action lawsuit against Aldeyra Therapeutics, seeking to recover damages for investors.

United States — Food and Drug Administration: The United States — Food and Drug Administration issued safety warnings concerning serious neurological complications in dogs treated with Bedinvetmab, which contributed to weakening prescription growth for Zoetis' product.

Bronstein, Gewirtz & Grossman, LLC: Bronstein, Gewirtz & Grossman, LLC is an investor-rights law firm that has filed a class action lawsuit against Zoetis on behalf of investors who purchased its securities during the Class Period.

United States — Food and Drug Administration: The United States — Food and Drug Administration issued a warning letter to ImmunityBio regarding misleading efficacy claims made by Patrick Soon-Shiong about Anktiva, which triggered the stock price drop and subsequent lawsuits.

Bronstein, Gewirtz & Grossman, LLC: Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against ImmunityBio and its officers, alleging violations of federal securities laws.